Adverse Drug Reaction (ADR) is the harmful or unpleasant reaction resulting from the usage of any medical product. ADR will require the action of either discontinuing the drug or reducing the drug dosage. ADR results in one of the following outcomes; Death, Life-threatening, Hospitalization (initial or prolonged), Disability - significant, persistent, or permanent change, impairment, damage or disruption in the patients body function/structure, physical activities or quality of life, Congenital abnormality.
Clinical Investigations in Adverse Drug reaction helps mitigate the effects or negate the predicted dangerous outcome by timely intervention. Journal of Biomedical Research & Environmental Sciences organizes research studies and case studies that help scientists and researchers discover and invent ways to deal with ADR.
Similar Subject Articles
-
HMPV in Focus: Emerging Insights into a Silent Respiratory Threat
Muskan Kumari* -
Development of a Fluorescence Isothermal Recombinase Polymerase Amplification Assay for Rapid Detection of Feline Calicivirus
Yujun Zhu, Shuzhou Huang, Bihong Huang, Yuexiao Lian, Tongyuan Zhang, Feng Cong*, and Miaoli Wu* -
New Species of the Genus Papuacites Ingrisch, 2015 from the Solomon Islands and New Guinea (Orthoptera: Tettigoniidae: Agraeciini)
Sigfrid Ingrisch* -
A Mutational Pathway Leading to Thyroid Tumors During Medication for Feline Hyperthyroidism
Ryunosuke Kikuchi1,3*, Yumiko Kagawa2 and Rosario Placido Roberto da Costa3 -
Degrees of Freedom and Conserved Quantities in Golfer-Environment Systems: An Ecological Analysis of Visual Kinesthesis and Screw Dynamics in the Golf Swing
Wangdo Kim*
Current Issue Current Issue Articles
-
A patient with Intestinal Aspergillosis caused by Endoscopic Submucosal Dissection operation
Tingting Lou, Mengjia Zhang, Tingting Liu and Xueling Fang -
Unresolved Depression on Alleviating Health Research Burnout
Carol Nash* -
A Typical Neuroleptic Malignant Syndrome Presenting with Hyponatremia
Rustem O*, Ercan Y and Ozer O -
NUVATUL-MZ Ointment for the Treatment of Ganglion Cyst
Vama Bhavsar, Tulsi Bhatia, Nupur Shah, Zalak Dave, Mihir Y Parmar* and Prachi Pandey -
Whartons Jelly in Regenerative Joint Therapy: A Case for IND-Exempt Inclusion in Randomized Controlled Trials
Scott M Martin*
Relevant Topics from Biology Group
- Academic Journals in molecular synthesis
- Free Scholarly Resources of Python for Bioinformatics
- Current Research Study of gene therapy
- Medical Case Reports on Clinical Drug Trials
- Advanced Research Areas in Proteomics Science
- Journal Research Disciplines like Molecular Cloning
- Health Services Research in Molecular Medicine
- Clinical Investigations in Adverse Drug Reaction
- Advanced Research Areas in Agronomy
- Largest Open Access Journal for Botany
- Top Molecular Biology Journals
- Scientific Research on Polymerase Chain Reaction
- Current Research Study of Drug Interactions
- Best Published Papers in Bryology
- Articles Related to Quantitative Proteomics
- Research Scope of Analytical Biochemistry and Biophysics
- Clinical Investigations in Cell Biology
- Scientific Papers on Biomolecules
